Tagasi

ISO 10993-6:2016

Biological evaluation of medical devices -- Part 6: Tests for local effects after implantation

Üldinfo
Kehtiv alates 28.11.2016
Direktiivid või määrused
puuduvad

Standardi ajalugu

Staatus
Kuupäev
Tüüp
Nimetus
28.11.2016
Põhitekst
Põhitekst
ISO 10993-6:2016 specifies test methods for the assessment of the local effects after implantation of biomaterials intended for use in medical devices.
ISO 10993-6:2016 applies to materials that are
-      solid and non-absorbable,
-      non-solid, such as porous materials, liquids, gels, pastes, and particulates, and
-      degradable and/or absorbable, which may be solid or non-solid.
The test sample is implanted into a site and animal species appropriate for the evaluation of the biological safety of the material. These implantation tests are not intended to evaluate or determine the performance of the test sample in terms of mechanical or functional loading. This part of ISO 10993 can also be applied to medical devices that are intended to be used topically in clinical indications where the surface or lining might have been breached, in order to evaluate local tissue responses.
The local effects are evaluated by a comparison of the tissue response caused by a test sample to that caused by control materials used in medical devices whose clinical acceptability and biocompatibility characteristics have been established. The objective of the test methods is to characterize the history and evolution of the tissue response after implantation of a medical device/biomaterial including final integration or absorption/degradation of the material. In particular for degradable/absorbable materials, the degradation characteristics of the material and the resulting tissue response should be determined.
ISO 10993-6:2016 does not deal with systemic toxicity, carcinogenicity, teratogenicity or mutagenicity. However, the long-term implantation studies intended for evaluation of local biological effects might provide insight into some of these properties. Systemic toxicity studies conducted by implantation might satisfy the requirements of this part of ISO 10993. When conducting combined studies for evaluating local effects and systemic effects, the requirements of both standards is to be fulfilled.
*
*
*
PDF
197,98 € koos KM-ga
Paber
197,98 € koos KM-ga
Standardi monitooring

Teised on ostnud veel

Põhitekst

ISO 10993-17:2002

Biological evaluation of medical devices -- Part 17: Establishment of allowable limits for leachable substances
Kehtetu alates 13.09.2023
Põhitekst

ISO/TS 16775:2014

Packaging for terminally sterilized medical devices -- Guidance on the application of ISO 11607-1 and ISO 11607-2
Kehtetu alates 05.11.2021
Põhitekst

ISO/TR 16197:2014

Nanotechnologies -- Compilation and description of toxicological screening methods for manufactured nanomaterials
Uusim versioon Kehtiv alates 12.05.2014
Põhitekst

ISO/TS 10993-20:2006

Biological evaluation of medical devices -- Part 20: Principles and methods for immunotoxicology testing of medical devices
Uusim versioon Kehtiv alates 03.08.2006